AnaptysBio, Inc.
ANAB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $123 | $36 | $71 | $496 |
| Short-Term Investments | $262 | $355 | $370 | $52 |
| Receivables | $41 | $7 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $9 | $5 | $5 |
| Total Curr. Assets | $432 | $407 | $447 | $554 |
| Property Plant & Equip (Net) | $16 | $18 | $20 | $22 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $35 | $27 | $143 | $67 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $52 | $46 | $163 | $89 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $484 | $452 | $610 | $643 |
| Liabilities | – | – | – | – |
| Payables | $4 | $5 | $3 | $2 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $40 | $31 | $22 | $13 |
| Total Curr. Liab. | $45 | $37 | $26 | $16 |
| LT Debt | $368 | $16 | $18 | $19 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $311 | $304 | $251 |
| Total NC Liab. | $368 | $327 | $322 | $271 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $16 | $18 | $19 | $21 |
| Total Liabilities | $413 | $364 | $348 | $287 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$759 | -$614 | -$450 | -$322 |
| AOCI | $0 | -$1 | -$5 | -$0 |
| Other Equity | $830 | $703 | $718 | $679 |
| Total Equity | $71 | $88 | $262 | $356 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $484 | $452 | $610 | $643 |
| Net Debt | $246 | -$18 | -$52 | -$475 |